The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
NeoImmuneTech
Neonc Technologies, Inc.
Merck Sharp & Dohme LLC
VM Oncology, LLC
Blanco, Dr Antonio Calles MD
Sellas Life Sciences Group
Salubris Biotherapeutics Inc
Evopoint Biosciences Inc.
Aeglea Biotherapeutics
Incyte Corporation
Western Regional Medical Center